Novartis Ag (NVS) Free Cash Flow (2009 - 2026)

Novartis Ag (NVS) has 16 years of Free Cash Flow data on file, last reported at $346.0 million in Q1 2026.

• Quarterly Free Cash Flow rose 36.22% year-over-year to $346.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 billion (down 38.07% YoY) and the FY2025 annual result came in at $17.6 billion, up 8.26% from the prior year.
• Free Cash Flow fell to $346.0 million in Q1 2026 per NVS's latest filing, from $609.0 million in the prior quarter.
• The five-year high for Free Cash Flow was $7.7 billion in Q4 2024, with the low at $168.0 million in Q1 2023.
• Average Free Cash Flow over 5 years is $2.5 billion, with a median of $354.0 million recorded in 2025.
• The widest YoY moves for Free Cash Flow: up 36.22% in 2025, down 92.09% in 2025.
• Novartis Ag's Free Cash Flow stood at $5.7 billion in 2022, then rose by 21.52% to $6.9 billion in 2023, then climbed by 10.94% to $7.7 billion in 2024, then slumped by 92.09% to $609.0 million in 2025, then slumped by 43.19% to $346.0 million in 2026.
• Business Quant data shows NVS's Free Cash Flow at $346.0 million in Q1 2026, $609.0 million in Q4 2025, and $354.0 million in Q3 2025.